Evidence map›Paper›PMID 17030648›Full record

ArticleArchives of neurology2006

Mediterranean diet, Alzheimer disease, and vascular mediation.

Nikolaos Scarmeas, Yaakov Stern, Richard Mayeux, Jose A Luchsinger

Open access · greenAbstract read
In one paragraph

Article in Archives of neurology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 163 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed, 10 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 10 syntheses or guidelines pooled it, 426 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Dietary pattern in relation to the risk of Alzheimer's disease: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016
    Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nikolaos ScarmeasTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY 10032, USA. ns257@columbia.edu
Yaakov Stern
Richard Mayeux
Jose A Luchsinger
Columbia University Irving Medical Center · US

Funding

ZOLEDRONIC ACID IN PROSTATE CANCERM01RR000645 · NCRR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI COLTEN, HARVEY R · 1985 to 2006
$27.0M
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEP01AG007232 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LUCHSINGER, JOSE ALEJANDRO · 1989 to 2008
$21.7M
CORE--METHODS AND DATAP30AG015294 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CARRASQUILLO, OLVEEN · 1997 to 2006
$4.8M
Mediterranean Diet and Other Dietary Patterns in Alzheimer's DiseaseR01AG028506 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCARMEAS, NIKOLAOS A · 2008 to 2012
$2.0M
Vascular factors, amyloid beta, and Alzheimer's diseaseK08AG020856 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LUCHSINGER, JOSE A · 2002 to 2004
$564k
NCRR NIH HHS M01 RR000645NCRR NIH HHS RR00645NIA NIH HHS 1K08AG20856-01NIA NIH HHS AG07232NIA NIH HHS AG07702NIA NIH HHS AG15294-06NIA NIH HHS K08 AG020856NIA NIH HHS P01 AG007232NIA NIH HHS P30 AG015294NIA NIH HHS R01 AG028506
6 · The paper itself

Abstract

objectivesTo examine the association between the Mediterranean diet (MeDi) and Alzheimer disease (AD) in a different AD population and to investigate possible mediation by vascular pathways. Design, Setting, Patients, and

main outcome measuresA case-control study nested within a community-based cohort in New York, NY. Adherence to the MeDi (0- to 9-point scale with higher scores indicating higher adherence) was the main predictor of AD status (194 patients with AD vs 1790 nondemented subjects) in logistic regression models that were adjusted for cohort, age, sex, ethnicity, education, apolipoprotein E genotype, caloric intake, smoking, medical comorbidity index, and body mass index (calculated as weight in kilograms divided by height in meters squared). We investigated whether there was attenuation of the association between MeDi and AD when vascular variables (stroke, diabetes mellitus, hypertension, heart disease, lipid levels) were simultaneously introduced in the models (which would constitute evidence of mediation).

resultsHigher adherence to the MeDi was associated with lower risk for AD (odds ratio, 0.76; 95% confidence interval, 0.67-0.87; P<.001). Compared with subjects in the lowest MeDi tertile, subjects in the middle MeDi tertile had an odds ratio of 0.47 (95% confidence interval, 0.29-0.76) and those at the highest tertile an odds ratio of 0.32 (95% confidence interval, 0.17-0.59) for AD (P for trend <.001). Introduction of the vascular variables in the model did not change the magnitude of the association.

conclusionsWe note once more that higher adherence to the MeDi is associated with a reduced risk for AD. The association does not seem to be mediated by vascular comorbidity. This could be the result of either other biological mechanisms (oxidative or inflammatory) being implicated or measurement error of the vascular variables.

Indexed as

Diet, MediterraneanAgedAged, 80 and overAge FactorsAlzheimer DiseaseApolipoproteins EBody Mass IndexCase-Control StudiesCohort StudiesComorbidityEducationEnergy IntakeEthnicityFemaleGenotypeHumansApolipoproteins E

Identifiers

PMID17030648
PMCPMC3024906
OpenAlexW2114509850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.